MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Herbert Tilg who is the Head of Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria on on the Recent Advances in Clinical Practice paper "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications" published in paper copy in Gut in April 2024. Read the paper: https://gut.bmj.com/content/73/4/691 Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). 

Om Podcasten

The Gut Podcast is your go-to source for the latest discussions in gastroenterology and hepatology. Each month Dr. Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, dives into key issues in the field by discussing articles with their authors. Gut - gut.bmj.com - is an international journal from BMJ Group and the British Society of Gastroenterology (BSG) publishing research and review articles in gastroenterology and hepatology. Stay up to date with the latest research in gastroenterology. Subscribe to the Gut podcast. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.